Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17484748 | 0.76 | FBP1 (0.37) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL17484749 | 0.74 | LMNA (0.38) | KDM4EALDH1A1SMN1; SMN2PDE10ACYP2A6 | |
| SCHEMBL20626747 | 0.72 | LMNA (0.41) | KDM4EALDH1A1 | |
| SCHEMBL17482196 | 0.62 | MET (0.47) | KDM4EALDH1A1SMN1; SMN2CYP2A6 | |
| SCHEMBL17482201 | 0.61 | PDE10A (0.33) | KDM4EALDH1A1SMN1; SMN2PDE10ACYP2A6 | |
| SCHEMBL1164441 | 0.61 | LMNA (0.41) | KDM4EALDH1A1SMN1; SMN2PDE10ACYP2A6 | |
| SCHEMBL20626725 | 0.60 | MAPT (0.55) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL21623963 | 0.58 | KDM4E (0.45) | KDM4EALDH1A1SMN1; SMN2CYP2A6 | |
| SCHEMBL19902460 | 0.57 | PDE4A (0.36) | KDM4EALDH1A1SMN1; SMN2PDE10APDE4A | |
| SCHEMBL24135327 | 0.57 | KDM4E (0.41) | KDM4EALDH1A1SMN1; SMN2PDE10ACYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174064-B2 | Photoactive energetic materials | TRIAD NATIONAL SECURITY, LLC (US) | 2019-01-08 | — | — | US | disclosed |
| US-9902748-B2 | Photoactive energetic materials | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2018-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10174064-B2 | Photoactive energetic materials | NOX5, TRPM5, MT-ND5 | KDM4E 3658/4885ALDH1A1 706/4885SMN1; SMN2 4635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.